The New York Times – Business:
Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there is broader trouble with the data center build-out.
The New York Times – Business:
Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there is broader trouble with the data center build-out.
The New York Times – Business:
Despite strong revenues and profits, the streaming service cut 1,000 jobs and jettisoned its chief content officer. Drops in the stock price and viewer engagement are to blame.
The New York Times – Business:
Commercials with Sydney Sweeney promoting a gambling platform and Megan Fox endorsing male enhancement have rankled fans, and even athletes. Who is in charge?
The New York Times – Business:
Higher interest rates are inflating borrowing costs as the Trump administration spends on the Iran war and tariff refunds.
The New York Times – Business:
The bank was required to hold the certificate of deposit only for a limited time, and now has no record of the money. Experts offer tips to avoid having this happen to you.
The New York Times – Business:
Kevin Warsh, the central bank’s chairman, suggested he wouldn’t push to raise borrowing rates this month. But persistent inflation may force the Fed’s hand.
The New York Times – Business:
The potential downgrade by MSCI, an influential index provider, adds to a deepening crisis of investor confidence in the economic policies of Indonesian President Prabowo Subianto.
The New York Times – Business:
The booking giant is accused of breaking federal antitrust laws and forcing millions of customers to overspend on stays by as much as 30 percent.
The New York Times – Business:
Lufthansa’s quirky plane, with its extra-long fuselage, four engines and restrooms down a flight of stairs, has a devoted following. Now, the carrier, one of few still flying the model, is taking it out of service.
The New York Times – Business:
President Trump has been promoting his efforts to reduce drug prices, but many Americans have not seen relief from rising costs for prescriptions and insurance premiums.